Sitka Biopharma
Transforming chemotherapies to further benefit patients by enhancing efficacy and improving tolerability.
Launch date
Employees
Market cap
-
Enterprise valuation
€4—7m (Dealroom.co estimates Feb 2019.)
Vancouver British Columbia (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
N/A | Seed | ||
N/A | Seed | ||
$2.4m | Seed | ||
$2.4m | Seed | ||
$1.9m | Early VC | ||
$1.2m | Early VC | ||
Total Funding | €7.2m |
Related Content
Recent News about Sitka Biopharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.